Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Drug giants Novo Nordisk and Pfizer are locked in a fierce $9 billion bidding war for obesity drug developer Metsera. Novo's ...

After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

Licensing remains a dominant model. The value of the licensing-out deals signed by Chinese biotech firms in the first half of ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

The Swiss pharma is paying $12 billion for Avidity Biosciences and its three late-stage antibody oligonucleotide conjugates.

In December 2021, former NFL wide receiver Demaryius Thomas was found unconscious at his home in Georgia and later pronounced dead at age 33. Thomas, who played in the NFL from 2010-19, was ...

Construction of a new $95 million Coriell Institute Strategic Innovation Center is underway in Camden. The building is expected to open in early 2028. The location, which was announced in February, ...

Another spat between the leaders of the world’s two largest economies has quickly escalated, and if President Donald Trump and Chinese President Xi Jinping don’t lower the temperature soon, both ...

TRON: Ares opened in theaters this past weekend, and it ends with Evan Peters' villainous Julian Dillinger managing to escape into a Grid of his own making, avoiding being made to pay for his actions.